Tatiana Zhuravskaya

Health Technology

Profile

Tatiana Zhuravskaya is a Partner and Director of FDS Pharma.
She is Chief Executive Officer of ASGL-Research Laboratories.
Ms. Zhuravskaya is Chief Scientific Advisor of the Baltic Pharmaceutical Society.
She served as Non-Executive Director of Lipoxen Plc until October 6, 2008.
Prior to joining Lipoxen, Ms. Zhuravskaya worked as a Clinical Scientist at Public Health Laboratory Services (London).
From 1997 to 1998, she was a Clinical Researcher in the Neurology Department of the University of Pennsylvannia.
Ms. Zhuravskaya received a Medical Degree from the Medical School in St Petersburg and a PhD in Cell and Molecular Biology from the University of Nevada.

Former positions of Tatiana Zhuravskaya

Companies	Position	End
Xenetic Biosciences (UK) Ltd. Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom.	Director/Board Member	05/10/2008

See the detail of Tatiana Zhuravskaya's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies